AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 050 GBX
-0.87%
Market Closed
Updated:
May 6, 2024
AstraZeneca PLC
EPS (Diluted)
|
AstraZeneca PLC
EPS (Diluted) Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$3
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
EPS (Diluted)
$0
|
CAGR 3-Years
29%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's EPS (Diluted)?
EPS (Diluted)
3.8
USD
3.8
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's EPS (Diluted) amounts to 3.8 USD.
What is AstraZeneca PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
6%
6%
Over the last year, the EPS (Diluted) growth was 81%. The average annual EPS (Diluted) growth rates for AstraZeneca PLC have been 16% over the past three years , 18% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
